Dimemorfan

Dimemorfan
Clinical data
Trade names	Astomin, Datosin, Gentus
Other names	Dimemorfan phosphate; Dimemorphan; 3,17-Dimethylmorphinan;
AHFS/Drugs.com	International Drug Names
ATC code	R05DA11 (WHO) ;
Identifiers
	IUPAC name (4bS,8aS,9S)-3,11-Dimethyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene;
CAS Number	36309-01-0 ;
PubChem CID	3037918;
DrugBank	DB13810 ;
ChemSpider	16735785 ;
UNII	623OAC38YU;
KEGG	D07848 ;
ChEMBL	ChEMBL2106325 ;
CompTox Dashboard (EPA)	DTXSID301043335 ;
ECHA InfoCard	100.048.134
Chemical and physical data
Formula	C18H25N
Molar mass	255.405 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=CC2=C(C[C@@H]3N(CC[C@@]42CCCC[C@H]34)C)C=C1;
	InChI InChI=1S/C18H25N/c1-13-6-7-14-12-17-15-5-3-4-8-18(15,16(14)11-13)9-10-19(17)2/h6-7,11,15,17H,3-5,8-10,12H2,1-2H3/t15-,17+,18+/m1/s1 ; Key:KBEZZLAAKIIPFK-NJAFHUGGSA-N ;
	(what is this?) (verify)

Dimemorfan (INN; JAN dimemorfan phosphate; also known as dimemorphan and 3,17-dimethylmorphinan; brand names Astomin, Dastosirr, and Tusben) is an antitussive (cough suppressant) of the morphinan family that is widely used in Japan and is also marketed in Spain and Italy. It was developed by Yamanouchi Pharmaceutical (now Astellas Pharma) and introduced in Japan in 1975. It was later introduced in Spain in 1981 and Japan in 1985.